The cell toxicity effect of secalonic acid D on GH3 cells and the related mechanisms

Guizhi Liao1, Jing Zhou, Hui Wang

  • 1Department of Histology and Embryology, Sun Yat-sen University, Guangzhou, Guangdong, PR China.

Oncology Reports
|January 1, 2010
PubMed

Insights

Secalonic acid D (SAD) from marine microbes effectively inhibits pituitary adenoma GH3 cells by inducing apoptosis and suppressing growth hormone. Further in vivo studies are recommended for this potential anti-pituitary tumor drug.

Area of Science:

  • Marine Microbiology
  • Pharmacology
  • Cell Biology

Background:

  • Pituitary adenomas are common tumors.
  • Marine microorganisms are a source of novel bioactive compounds.
  • Secalonic acid D (SAD) is a compound with potential therapeutic applications.

Purpose of the Study:

  • To investigate the anti-pituitary adenoma effects of secalonic acid D (SAD).
  • To evaluate the cytotoxic effects of SAD on GH3 cells.
  • To elucidate the mechanism of SAD-induced apoptosis and its effect on growth hormone (GH) expression.

Main Methods:

  • MTT assay for cell proliferation and IC50 determination.
  • Hoechst staining, Tunel assay, and flow cytometry for apoptosis analysis.
  • Western blotting, RT-PCR, and caspase inhibitor (Z-VAD-FMK) for mechanistic studies.

Main Results:

  • SAD exhibited time- and dose-dependent cytotoxicity against GH3 cells.
  • Cytotoxicity was primarily mediated through apoptosis, involving caspase family activation and G1/S phase cell cycle arrest.
  • SAD suppressed GH expression in GH3 cells, but not by altering GH mRNA levels.

Conclusions:

  • Secalonic acid D demonstrates potential as an anti-pituitary tumor agent.
  • Apoptosis induction and GH suppression are key mechanisms of SAD's action.
  • Further in vivo studies are warranted to validate the therapeutic potential of SAD.

Related Concept Videos